JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 77 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $592,000 | +18.2% | 72,607 | 0.0% | 0.08% | +3.7% |
| Q2 2020 | $501,000 | -2.5% | 72,607 | -32.9% | 0.08% | -21.2% |
| Q1 2020 | $514,000 | -45.6% | 108,204 | 0.0% | 0.10% | -10.3% |
| Q4 2019 | $945,000 | +162.5% | 108,204 | 0.0% | 0.12% | +123.1% |
| Q3 2019 | $360,000 | – | 108,204 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $9,152,000 | 93.42% |
| Ally Bridge Group (NY) LLC | 550,000 | $3,735,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 813,500 | $5,524,000 | 2.58% |
| TRV GP III, LLC | 1,148,780 | $7,800,000 | 2.12% |
| Deep Track Capital, LP | 4,259,653 | $28,923,000 | 1.86% |
| Logos Global Management LP | 1,400,000 | $9,506,000 | 1.23% |
| PFM Health Sciences, LP | 3,972,868 | $26,976,000 | 1.01% |
| Sofinnova Investments, Inc. | 1,481,219 | $10,057,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 248,347 | $1,686,000 | 0.70% |
| RTW INVESTMENTS, LP | 4,680,412 | $31,780,000 | 0.66% |